Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,311 papers from all fields of science
Search
Sign In
Create Free Account
U 101033E
Known as:
U-101033E
, U101033E
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Pyrimidines
Pyrrolidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants
J. Karlsson
,
M. Emgård
,
P. Brundin
Brain Research
2002
Corpus ID: 30528552
2000
2000
Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent α-phenyl-N-tert-butyl nitrone (PBN)
R. Schmid-Elsaesser
,
E. Hungerhuber
,
S. Zausinger
,
A. Baethmann
,
H. Reulen
Experimental Brain Research
2000
Corpus ID: 21132468
Abstract Literature on the therapeutic efficacy of free radical scavengers suggests that drugs that are able to cross the blood…
Expand
2000
2000
Der neuroprotektive Einfluss des Glutamat-Antagonisten Acamprosat nach experimenteller zerebraler Ischämie Ein Vergleich mit dem Lipidperoxidase-Inhibitor U-101033E
K. Engelhard
,
C. Werner
,
H. Lu
,
O. Möllenberg
,
W. Zieglgänsberger
,
E. Kochs
Der Anaesthesist
2000
Corpus ID: 43462926
ZusammenfassungFragestellung. Die vorliegende experimentelle Studie untersucht den Einfluss von Acamprosat, einem glutamatergen…
Expand
1999
1999
Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia
R. Schmid-Elsaesser
,
E. Hungerhuber
,
S. Zausinger
,
A. Baethmann
,
H. Reulen
Brain Research
1999
Corpus ID: 40078754
1998
1998
Inhibition of peroxynitrite-mediated tyrosine nitration by a novel pyrrolopyrimidine antioxidant.
Troy T. Rohn
,
Mark T. Quinn
European Journal of Pharmacology
1998
Corpus ID: 7075516
1998
1998
Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats.
M. Soehle
,
A. Heimann
,
O. Kempski
Stroke
1998
Corpus ID: 11523546
BACKGROUND AND PURPOSE The lipid peroxidation inhibitor U-101033E was examined for effects on cerebral blood flow (CBF), cortical…
Expand
Highly Cited
1997
Highly Cited
1997
Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats.
Y. Xiong
,
P. Peterson
,
J. Muizelaar
,
C. Lee
Journal of Neurotrauma
1997
Corpus ID: 23266162
In the present study, a severe traumatic brain injury (TBI) was produced over the right parietal cortex of rats using the…
Expand
1997
1997
Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
R. Schmid-Elsaesser
,
S. Zausinger
,
E. Hungerhuber
,
N. Plesnila
,
Alexander Baethmann
,
H. Reulen
Stroke
1997
Corpus ID: 22686501
BACKGROUND AND PURPOSE The vascular endothelium and parenchyma of the brain have the potential to generate free radicals under…
Expand
1997
1997
Neuroprotective properties of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
R. Schmid-Elsaesser
,
S. Zausinger
,
E. Hungerhaber
,
Alexander Baethmann
,
H. Reulen
Acta neurochirurgica. Supplement
1997
Corpus ID: 21919496
Many efforts have been undertaken to develop antioxidants against free radical induced brain damage, 21-aminosteroids, although…
Expand
1996
1996
Two Novel Pyrrolopyrimidine Lipid Peroxidation Inhibitors U-101033E and U-104067F Protect Facial Motor Neurons Following Neonatal Axotomy
Sarah L. Smith
,
J. Oostveen
,
E. Hall
Experimental Neurology
1996
Corpus ID: 27298922
Recent reports suggest that oxygen radical-induced lipid peroxidation plays a role in the retrograde degeneration of motor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE